Wat is de prijs voor Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Het prijs van Hunan Er-Kang Pharmaceutical Co., Ltd (300267) is $0.48835979

Wat is de marktkapitalisatie voor Hunan Er-Kang Pharmaceutical Co., Ltd (300267)

Marktkapitalisatie voorHunan Er-Kang Pharmaceutical Co., Ltd (300267) is $1.01B

Hunan Er-Kang Pharmaceutical Co., Ltd (300267) WPA

Hunan Er-Kang Pharmaceutical Co., Ltd is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients (APIs), completed drug formulations, and pharmaceutical excipients, serving both the Chinese domestic market and international clients. Its API portfolio features substances such as glycerin, dilute hydrochloric acid, sulbenicillin sodium, calamine powder, sulfadiazine, sulphaguanidine, TMP, and resorcinol. The company's principal finished medications include sulbenicillin sodium for injection and compound liquorice tablets. For conventional pharmaceutical excipients, it provides items like pharmaceutical glycerin, medicinal ethanol, medicinal propylene glycol, medicinal sodium hydroxide, and sucrose. Furthermore, its advanced pharmaceutical excipient offerings encompass hydroxypropyl starch empty capsules, hydroxypropyl starch soft capsules, and citrate along with its related product series. The firm was established in 2003 and is headquartered in Liuyang, China.

Jaar	EPS	Wijzigen
Niet genoeg gegevens voor de verstrekte datums.

Jaar

EPS

Wijzigen

Niet genoeg gegevens voor de verstrekte datums.

Bedrijf	EPS	EPS-verschil	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$0.56	-	IN

Bedrijf

EPS

EPS-verschil

Land